3

VDR-BsmI and VDR-FokI genotypes alone or combined with smoking duration and obesity compared between 120 melanoma cases and 120 healthy controls.

Single or combined variableMelanoma cases (n=120), n (%) Healthy controls (n=120), n (%) OR (CI), P (Melanomas vs. healthy controls) MetM (n=52), n (%) NMetM (n=68), n (%) OR (CI), P (MetM vs. NMetM) OR (CI), P (MetM vs. healthy controls) OR (CI), P (NMetM vs. healthy controls)
BB30 (25.0)31 (25.8)0.96 (0.53–1.71), 0.88211 (21.2)19 (27.9)0.69 (0.30–1.62), 0.3950.77 (0.35–1.68), 0.5121.11 (0.57–2.17), 0.753
Bb64 (53.3)56 (46.7)1.31 (0.79–2.17), 0.30224 (46.2)40 (58.8)0.60 (0.29–1.24), 0.1680.98 (0.51–1.88), 0.9511.63 (0.89–2.98), 0.109
bb26 (21.7)33 (27.5)0.73 (0.40–1.32), 0.29417 (32.7)9 (13.2)3.18 (1.28–7.91), 0.0101.28 (0.63–2.59), 0.4910.40 (0.18–0.90), 0.024
BB+Bb (B allele)94 (78.3)87 (72.5)1.37 (0.76–2.48), 0.29435 (67.3)59 (86.8)0.31 (0.13–0.78), 0.0100.78 (0.39–1.58), 0.4912.49 (1.11–5.58), 0.024
Bb+bb (b allele)90 (75.0)89 (74.2)1.04 (0.58–1.87), 0.88241 (78.8)49 (72.1)1.44 (0.62–3.38), 0.3951.30 (0.59–2.83), 0.5120.90 (0.46–1.75), 0.753
bb plus ≥20 years ever-smoking9 (7.5)2 (1.7)4.78 (1.01–22.6), 0.0317 (13.5)2 (2.9)5.13 (1.02–25.8), 0.0399.18 (1.84–45.8), 0.0041.79 (0.25–13.0), 0.621
Bb+bb plus ≥20 years ever-smoking28 (23.3)14 (11.7)2.30 (1.14–4.64), 0.01718 (34.6)10 (14.7)3.07 (1.27–7.41), 0.0114.01 (1.80–8.90), <0.0011.30 (0.55–3.12), 0.549
bb plus BMI >30 kg/m24 (3.3)0 (–)a3 (5.8)1 (1.5)4.10 (0.41–40.6), 0.315aa
Bb+bb plus BMI >30 kg/m213 (10.8)4 (3.3)3.52 (1.11–11.1), 0.0248 (15.4)5 (7.4)2.29 (0.70–7.47), 0.1615.27 (1.51–18.4), 0.0082.30 (0.60–8.88), 0.288
Bb+bb plus ≥20 years ever-smoking, and plus BMI >30 kg/m29 (7.5)1 (0.8)9.65 (1.20–77.4), 0.0108 (15.4)1 (1.5)12.2 (1.47–101), 0.01021.6 (2.63–178), <0.0011.78 (0.11–28.9), 1.00
FF47 (39.2)54 (45.0)0.79 (0.47–1.31), 0.36017 (32.7)30 (44.1)0.61 (0.29–1.30), 0.2040.59 (0.30–1.17), 0.1320.96 (0.53–1.76), 0.907
Ff60 (50.0)50 (41.7)1.40 (0.84–2.33), 0.19529 (55.8)31 (45.6)1.50 (0.73–3.11), 0.2691.76 (0.91–3.40), 0.088^1.17 (0.64–2.14), 0.602
ff13 (10.8)16 (13.3)0.79 (0.36–1.72), 0.5526 (11.5)7 (10.3)1.14 (0.36–3.61), 0.8280.85 (0.31–2.31), 0.7460.75 (0.29–1.91), 0.541
FF+ff (F allele)107 (89.2)104 (86.7)1.27 (0.58–2.76), 0.55246 (88.5)61 (89.7)0.88 (0.28–2.79), 0.8281.18 (0.43–3.21), 0.7461.34 (0.52–3.44), 0.541
Ff+ff (f allele)73 (60.8)66 (55.0)1.27 (0.76–2.12), 0.36035 (67.3)38 (55.9)1.62 (0.77–3.45), 0.2041.68 (0.85–3.33), 0.1321.04 (0.57–1.89), 0.907
Ff plus ≥20 years ever-smoking19 (15.8)7 (5.8)3.04 (1.23–7.52), 0.01312 (23.1)7 (10.3)2.61 (0.95–7.21), 0.057^4.84 (1.78–13.2), 0.0011.85 (0.62–5.53), 0.263
Ff+ff plus ≥20 years ever-smoking24 (20.0)9 (7.5)3.08 (1.37–6.95), 0.00515 (28.8)9 (13.2)2.66 (1.06–6.69), 0.0345.00 (2.02–12.4), <0.0011.88 (0.71–4.99), 0.199
Ff plus BMI >30 kg/m29 (7.5)2 (1.7)4.78 (1.01–22.6), 0.0315 (9.6)4 (5.9)1.70 (0.43–6.68), 0.4996.28 (1.18–33.5), 0.0273.69 (0.66–20.7), 0.191
Ff+ff plus BMI >30 kg/m212 (10.0)2 (1.7)6.56 (1.43–30.0), 0.0067 (13.5)5 (7.4)1.96 (0.58–6.57), 0.2699.18 (1.84–45.8), 0.0044.68 (0.88–24.8), 0.101
Ff+ff plus ≥20 years ever-smoking, and plus BMI >30 kg/m26 (5.0)0 (–)a6 (11.5)0 (–)aaa

aOR uncountable because one or two of the compared groups had zero subject. Significant differences were indicated in bold, tendencies were evidenced with superscript ^.